Biovac A Administration and Recommendations
Based on FDA labeling, Biovac A is a homeopathic product (Bovista 30C HPUS) taken orally as three pills daily, NOT a hepatitis A vaccine—this is fundamentally different from hepatitis A vaccines discussed in ACIP guidelines. 1
Critical Distinction
The FDA-labeled Biovac A product is a homeopathic preparation with the following specifications:
- Active ingredient: Bovista 30C HPUS (a homeopathic dilution)
- Route: Oral administration
- Dosing: Three pills daily, 30 minutes away from food
- Pregnancy/breastfeeding: Consult healthcare professional before use 1
This is NOT the live attenuated hepatitis A vaccine also called "Biovac" referenced in research literature 2.
If You Need Hepatitis A Vaccination Guidance
For actual hepatitis A immunization (using inactivated vaccines like Havrix or Vaqta), follow ACIP 2018 recommendations:
Routine Vaccination Schedule
- Children 12-23 months: Initiate 2-dose series
- Second dose: Administer at least 6 months after first dose 3
Postexposure Prophylaxis (within 14 days of exposure)
- Age 12 months-40 years (healthy): 1 dose vaccine alone
- Age >40 years (healthy): 1 dose vaccine + consider immune globulin 0.1 mL/kg based on risk assessment
- Immunocompromised or chronic liver disease (≥12 months): 1 dose vaccine + 0.1 mL/kg immune globulin simultaneously at different anatomic sites 3
International Travel
- Infants 6-11 months: 1 dose before travel (does not count toward routine series)
- ≥12 months: 1 dose as soon as travel considered, complete series per routine schedule 3
Contraindications
Life-threatening allergic reaction to previous hepatitis A vaccine dose or any vaccine component 3
Common Pitfall
Do not confuse the homeopathic Biovac A product with hepatitis A vaccines. The homeopathic preparation has no established efficacy for hepatitis A prevention based on conventional medical standards. Research on a live attenuated vaccine also called "Biovac" showed inferior long-term immunogenicity compared to inactivated vaccines 2.